Creates the Medical Research Supply Assurance and Trade Resilience Act to safeguard critical research and medical supply chains against global trade disruptions.

Summary

The bill orders the Alabama Department of Public Health to create a grant program, a strategic stockpile of key biomedical items, and a board to monitor supply‑chain risks. Hospitals, research universities, biotech firms and other health facilities could receive funding and access to the reserve when tariffs or other trade problems raise costs or cause shortages. The aim is to keep the state’s health and biotech sectors operating smoothly despite global trade disruptions.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share